$SPCXBullishMed

SpaceX Stock Gains More Than 20% After Market Debut

SpaceX’s IPO on June 12 priced shares at $135 and began trading at $150, closing Friday at $160.95. The stock rose about 19% on day one and was up another ~6% in premarket June 15 near $170. SpaceX raised $75 billion at a $1.77 trillion valuation. Analysts cited elevated valuation; CFRA set a $115 “sell” target and Morningstar called it overvalued. Investors will watch the 180-day lock-up expiry.

7/10
4/10
Med
Bullish
Premarket today (June 15) after IPO debut on June 12
Risk-on momentum (shares up ~20% post-IPO) tempered by valuation bears (CFRA sell; Morningstar overvalued)

Near-term trading is dominated by IPO momentum versus valuation skepticism and the upcoming 180-day lock-up expiration.

SpaceX’s IPO priced at $135 and the stock jumped ~19% on day one, with premarket trading near $170 and lock-up risk ahead.

Elevated volatility likely around lock-up expiry; near-term price action may remain momentum-driven while valuation bears cap upside.

Background

SpaceX held a record-setting IPO on June 12, priced at $135 per share, and began trading the prior Friday.

Why it matters

The text frames the trade as a momentum-driven IPO pop versus valuation skepticism, with a clear future supply overhang when the 180-day lock-up ends.

Market relevance

A high-profile IPO with immediate price momentum and a specific future catalyst (lock-up expiry) creates a tradable volatility window.

Market effects

Highlights investor appetite for commercial space and satellite internet exposure, but also underscores valuation sensitivity in high-profile IPOs.

Primarily US-listed IPO sentiment; may influence broader US growth/IPO risk appetite.

Space/telecom capital-markets narrative could affect global investor positioning toward satellite and launch economics.

Alternative perspectives

Despite the strong debut, valuation-focused notes (CFRA, Morningstar) imply downside risk if post-lock-up selling overwhelms momentum.

The article flags the 180-day lock-up as the key next event; traders may also watch liquidity/float changes and any follow-on analyst coverage updates after debut.

Key entities

  • SpaceX

    Commercial space company behind Starlink and reusable rockets; IPO debut drove a >20% post-listing move in the article.

  • CFRA

    Initiated coverage with a “sell” rating and a $115 price target, citing elevated valuation.

  • Morningstar

    Pre-IPO note estimated fair value around $63 and called the stock overvalued.

Related articles

$SPCXMed

Beaten-down stock lets you buy SpaceX below market price

The article says Deutsche Bank initiated coverage of EchoStar (SATS) on July 7, framing it as a discounted way to own SpaceX. It cites a $143 price target and a claim that SATS offers about a 20% discount versus SpaceX. It notes EchoStar holds about $11 billion of SpaceX Class A shares, while EchoStar fell 23% since SpaceX’s IPO and is expected to report Q2 results July 30.

$SPCXMed

SpaceX Doubles Prices for Starlink Aviation Plans, Raises Hardware Cost to $200,000

Space Exploration Technologies (NASDAQ:SPCX) raised Starlink Business Aviation plan prices, according to a post on X. The Aviation Regional 25GB is $4,000/month (from $2,000), Regional Unlimited is $12,500/month, and Global Unlimited is $20,000/month (from $10,000). Starlink aviation hardware is $200,000 (from $145,000), with customer migration in August. Morgan Stanley cited a $600/share bull case.

$SPCXMed

SpaceX releases Grok 4.5, first model built alongside Cursor

SpaceX (NASDAQ:SPCX) released Grok 4.5, its first major AI model update built with Cursor for coding and agentic workflows. The 1.5T-parameter model was trained on tens of thousands of GB300 GPUs and follows Grok 4.3. SpaceX cites improved benchmark performance and lower pricing, $2 per 1M input tokens and $6 per 1M output. UBS reiterated a Buy and $210 target.

$SPCXMed

Elon Musk's Grok 4.5 Could Rewrite Enterprise AI Economics - SpaceX (NASDAQ:SPCX)

SpaceXAI, a wholly owned unit of Space Exploration Technologies Corp. (NASDAQ:SPCX), launched Grok 4.5 for coding and research-heavy tasks. The company says it is its strongest model and was trained alongside Cursor. Pricing is $2 per million input tokens and $6 per million output tokens, lower than Claude Opus 4.8, according to Counterpoint analyst Neil Shah. Shares were up 0.88% premarket at $149.60.

$SPCXMed

Jim Chanos Highlights Morgan Stanley's $672 Billion Funding Warning on Elon Musk's SpaceX - SpaceX (NASDA

Jim Chanos highlighted Morgan Stanley’s note on SpaceX’s funding needs, citing a multi-year external capital requirement of about $672 billion and no free-cash-flow positive period until 2035. Morgan Stanley kept an “Overweight” stance with a $300 price target, while warning SpaceX may need equity issuance or slower deployment if debt markets fail. SPCX listed June 12, 2026.